Pharmacovigilance and Pharmaceutical products

Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science of collecting, detecting, evaluating, monitoring and preventing adverse drug reactions. As such, pharmacovigilance focuses primarily on adverse drug reactions, or ADRs, which are defined as any response to a medicinal product that is harmful and unintended, including lack of efficacy (the requirement that this definition applies only to doses normally used for the prophylaxis, diagnosis or therapy of a disease, or for the modification of the function of a physiological disorder was excluded in the last amendment of the relevant legislation). Medication errors, such as overdose, misuse and abuse of a medicinal product, as well as exposure to a medicinal product during pregnancy and lactation, are also of interest, even without an adverse event, as they may result in an adverse drug reaction.

 

    Related Conference of Pharmacovigilance and Pharmaceutical products

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Pharmacovigilance and Pharmaceutical products Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in